CCLNK - 6810-80-8 LOMOTIL TABLETS PN:006131

  • MSDS: CCLNK
  • Manufacturer: G D SEARLE
  • Product Name: 6810-80-8 LOMOTIL TABLETS PN:006131
  • National Stock Number: 6505-00-118-1914
Product Identification

Product ID:6810-80-8 LOMOTIL TABLETS PN:006131
MSDS Date:05/20/1996
FSC:6505
NIIN:00-118-1914
MSDS Number: CCLNK

Responsible Party
G.D. SEARLE
CHICAGO, IL 60680
US

Emergency Phone: 847-982-7000

Info Phone: 847-982-7000

Cage: 04525

Contractor
G.D. SEARLE
5110 CHICAGO, IL 60680 US

Telephone: 847-982-7000

Cage: 04525

Ingredients

ATROPINE SULFATE

CAS: 55-48-1

RTECS: CK2450000

Fraction By Weight: 0.04%


EXCIPIENTS

Fraction By Weight: 95.96%


DIPHENOXYLATE HYDROCHLORIDE

CAS: 3810-80-8

RTECS: NS5300000

Fraction By Weight: 4%

Hazards

LD50 LC50 Mixture:ORAL RAT LD50 221MG/KG.
Routes of Entry: Inhalation:NO Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHAL/SKIN/EYE:NO INFO.INGEST:SHORT
TERM EXPO:NERVOUS SYS,ALLERGIC,GASTROINTESTINAL SYS,OVERDOSES MAY
RESULT IN ABNORMAL PUPIL SIZE,UNUSUAL EYE MOVEMENTS,BREATHING
DIFFICULTIES,COMA,DEATH.DIPHENOXYLAT E HCL OPIOID,PROUDCE ACUTE
TOXICITY SIMILAR TO THAT OBSERVED W/MORPHINE.OVERDOSAGES RESP
DEPRESS,NAU,VOMIT,DIZZ,(SUPPLE)
Explanation of Carcinogenicity:PER MSDS:CARCINOGEN STATUS:NO INFO
AVAILABLE.
Effects of Overexposure:NERVOUS SYS:NUMBNESS OF
EXTREMITIES,EUPHORIA,DEPRESS,MALAISE/LETHARGY,CONFUSION,SEDATION/DR
OWS,DIZZ,RESTLESSNESS,HEAD.ALELRGIC:SWELLING OF GUMS,ITCHING SKIN
RASH,SHORTNESS OF BREATH.GI SYS:VOMIT,NAU,L OSS OF
APPETITE,ABDOMINAL DISCOMFORT,PANCREATITIS,FEVER,RAPID HEART
BEAT,URINE RETENTION,FLUSING,DRYNES OF SKIN/MUC MEMB
Medical Cond Aggravated by Exposure:AVOID CONTACT IF:PEOPLE
W/ALLERGY/SENS TO DIPHENOXYLATE HCL/ATROPINE SULFATE,PREG/NURSING
FEMALES.PEOPLE W/INTESTINAL DISORDES,ULCERATING COLITIS,LIVER
DISORDERS,TAKING MAO INHIBITOR,TRANQUILZR (SUPP)

First Aid

First Aid:INHAL:REMOVE TO FRESH AIR,MONITOR BLOOD
PRESSURE,RESP,TEMP,GEN CONDITIONS.GET MED ATTN PROMPTLY.SKIN:REMOVE
CONTAMN CLOTH.WASH W/SOAP/WTAER.IRRIT DEVELOPS GET MED
ATTN.EYE:IMEMD FLUSH W/LG AMTS OF WAT ER FOR @15MINS.GET MED ATTN
PROMPTLY.INGEST:INDUCE VOMIT IF CONSC/CAN SAFETLY VOMIT.PROVIDE GEN
SUPPORT/MONITOR BLOOD PRESSURE/RESP/TEMP/GEN CONDITION.GET MED ATTN
PROMPTLY.DR:OVERDOSE INDUCE (SUPPLE)

Fire Fighting

Flash Point:NOT PROVIDE
Autoignition Temp:Autoignition Temp Text:NA
Lower Limits:NA
Upper Limits:NA
Extinguishing Media:USE DRY CHEM, CARBON DIOXIDE, WATER SPRAY, REGULAR
FOAM OR EXTINGUISHING AGENT SUITABLE FOR SURROUNDING FIRE.
Fire Fighting Procedures:EVACUATE AREA & FIGHT FIRE FROM SAFE
DISTANCE.AS IN ANY FIRE WEAR PRESSURE DEMAND SELF-CONTAINED
BREATHING APPARATUS & FULL PROTECTIVE GEAR.
Unusual Fire/Explosion Hazard:NONE SPECIFIED BY MANUFACTURER.

Accidental Release

Spill Release Procedures:VACUUM MATL W/HIGH EFFICIENCY PARTICULATE AIR
(HEPA) FILTERED VACUUM CLEANER OR WET SWEEP. COLLECT WASTE FOR
PROPER DISPOSAL.KEEP UNNECESSARY PEOPLE AWAY. DO NOT FLUSH SPILLED
MATL INTO SEWER.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling

Handling and Storage Precautions:USE W/ADEQUATE VENTILATION.AVOID
BREATHING DUST.AVOID CONTACT W/EYE/SKIN/CLOTH.NO SPECIAL STORAGE
PROVISIONS NECESSARY.CARE
Other Precautions:GLOVES:CMPD HAS NOT BEEN SPECIFICALLY EVALUATED FOR
GLOVE SUITABILITY. TARGET ORGANS:CENTRAL NERVOUS SYTEM,
GASTROINTESTINAL TRACT.CHRONIC EFFECTS:HI DOSE
EXPO(40-60MG/DAY)RESULT IN MORPHINE-LIKE EFFE CTS INCLUDE
EUPHORIA,PHY DEPENDENCE.

Exposure Controls

Respiratory Protection:RESP CHOICE VARY DEPENDING ON INDIVIDUAL
CIRCUMST.SPEC APPLICATION SHOULD BE EVALUATED TO DETERMINE IF
FOLLOWING RECOMMENDATIONS APPROPR:HEPA FILT CARTRI W/ADEQ VENTI BUT
W/SOME POT FOR EXPO;SUPP AIR RESP FOR W/O ADEQ VENTI;SCBA
FIRE/LIFE.
Ventilation:LOCAL EXHAUST VENTILATION.
Protective Gloves:CHEM RESISTANT GLOVES.(SEE OTHER PRECAU)
Eye Protection:SAFETY GLASSES.
Other Protective Equipment:LONG SLEEVES (IF POTENTIAL SKIN CONTACT) &
DISPOSABLE COVERALLS.
Work Hygienic Practices:NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health
AGGRAVATE CONDITIONS:OR BARBITURATES SHOULD DISCUSS THIS W/PHYSICIAN
BEF EXPO. HEALTH HAZ:DYSPHORIA,CONSTIPATION,URINARY
RETENTIAON,HYPOTENSION. 1STAID:VOMIT/GASTRIC LAVAGE/MECHAN ASSIT
RESP.SLURRY OF 100G ACTIVATED CHARCOAL ADMIN.RESP DEPRESS FROM
LOMOTIL USE PURE NARCOTIC ANTAGONIST(NALOXONE)0.4-2MG.

Chemical Properties

HCC:T6
Boiling Pt:B.P. Text:NA
Melt/Freeze Pt:M.P/F.P Text:NA
Decomp Temp:Decomp Text:NP
Vapor Pres:NA
Vapor Density:NA
Spec Gravity:NOT KNOWN
pH:NA
Viscosity:NA
Solubility in Water:NOT KNOWN.
Appearance and Odor:OFF-WHITE CRYSTALLINE POWDER.
Percent Volatiles by Volume:NA
Corrosion Rate:NP

Stability

Stability Indicator/Materials to Avoid:YES
NONT KNOWN.
Stability Condition to Avoid:NOT KNOWN.
Hazardous Decomposition Products:OXIDES OF NITROGEN AND SULFUR,
HYDROGEN CHLORIDE.

Disposal

Waste Disposal Methods:CARE SHOULD BE USED IN HNDLG.INCINERATE IN
APPROVED FACILITY.OBSERVE ALL FED/STATE/LOC REGS WHEN DISPO OF THIS
SUBSTANCE.SARA SEC 313:NA.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.